FIELD: medicine; pharmaceutics.
SUBSTANCE: invention relates to inhibitors of transport/absorption of phosphates in the gastrointestinal tract. The use of an agonist of guanylate cyclase C (GC-C) receptor in the treatment of hyperphosphatemia in a patient who needs it is disclosed.
EFFECT: invention provides for the expansion of the arsenal of means for a specific purpose.
11 cl, 22 dwg, 12 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS | 2004 |
|
RU2543350C2 |
| METHODS AND COMPOSITIONS FOR GASTROENTERIC UPSET THERAPY | 2004 |
|
RU2353383C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF GASTROINTESTINAL DISORDERS | 2014 |
|
RU2763796C2 |
| PEPTIDE ANTAGONISTS OF CALCITONIN CGRP FAMILY OF PEPTIDE HORMONES AND THEIR USE | 2017 |
|
RU2742826C2 |
| PEPTIDE ANTAGONISTS OF PEPTIDE HORMONES FROM THE CALCITONIN GROUP (CALCITONIN GENE-RELATED PEPTIDES (CGRP)) AND THEIR APPLICATION | 2013 |
|
RU2624016C2 |
| GIP AGONIST COMPOUNDS AND METHODS | 2015 |
|
RU2716985C2 |
| MULTIFUNCTIONAL FUSION PROTEINS AND THEIR USE | 2020 |
|
RU2815388C2 |
| INSULIN ANALOGUES | 2017 |
|
RU2769476C2 |
| OPTIONS, COMPOSITIONS, AND METHODS FOR USE OF ENDONUCLEASE CBLB | 2018 |
|
RU2779097C2 |
| VECTOR, CO-EXPRESSING MOLECULES FOR VACCINATION AND COSTIMULATORY MOLECULES | 2016 |
|
RU2714157C2 |
